We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

M:NYSEMacy's Inc Analysis

Data as of 2026-06-12 - not real-time

$25.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Macy's, Inc. has just reported a earnings beat with strong sales momentum, reinforcing the bullish technical picture – the price is sitting just above its 20‑day SMA and the MACD line remains above the signal, while volume is on an upward trend. However, the RSI is deep in overbought territory, suggesting short‑term caution despite the overall bullish trend. The DCF fair‑value estimate of roughly $26 per share places the current market price of $25 slightly below intrinsic value, and the 3% dividend yield with a modest 30% payout ratio underscores a sustainable income component. Fundamentally, revenue is growing modestly at about 2% YoY, margins remain thin, but free cash flow is positive and debt‑to‑equity is high, reflecting a leveraged balance sheet.
On the risk side, the stock exhibits a high beta of over 1.3 and a 30‑day volatility near 50%, indicating sensitivity to market swings and a historical max drawdown close to 30%. The consumer‑cyclical sector faces macro‑economic headwinds, and the company's leverage adds financial risk, though the dividend and cash‑flow profile provide a cushion. Given the blend of bullish technical signals, modest undervaluation, and dividend sustainability, the near‑term stance should be cautious, while medium‑ to long‑term outlook remains more favorable as the recovery gains traction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • Bullish MACD but elevated volatility
  • Recent earnings beat supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF suggests price undervaluation
  • Sustainable dividend yield
  • Improving sales trends and omnichannel execution

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash flow and dividend sustainability
  • Value-oriented metrics (low P/E, P/B)
  • Potential upside as consumer spending recovers

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin2.94%
P/E Ratio10.3
ROE14.36%
ROA3.37%
Debt/Equity105.62
P/B Ratio1.4
Op. Cash Flow$1.8B
Free Cash Flow$748.9M

Technical Analysis

TrendBullish
RSI74.9
Support$17.93
Resistance$25.05
MA 20$21.28
MA 50$20.03
MA 200$19.80
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$26.18
Target Price$21.50
Upside/Downside-14.14%
GradeUndervalued
TypeValue
Dividend Yield3.06%

Risk Assessment

Beta1.35
Volatility48.94%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.